• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Research
  • Biotech
    • Clinical Data
    • Venture Capital
    • Deals
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending Topics
    • Cell & Gene Therapy
    • COVID-19
  • Podcasts
  • Resources
    • Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Orphazyme

image-icon
Special Reports

Top 10 game-changing biotech layoffs in H1

At the halfway point for the year, Fierce Biotech looks back at some of the most important layoff events that have hit the industry in 2021.
Annalee Armstrong Jul 19, 2022 3:00am

Orphazyme meme ends with $13M sale to satisfy bankruptcy court

May 16, 2022 6:06am

Layoff 'wave' not letting up amid oversaturation of biotechs

Mar 28, 2022 10:05am

Orphazyme on last legs amid restructuring, more layoffs

Mar 10, 2022 6:24pm

Orphazyme to assess strategic options after EU advisers nix drug

Feb 24, 2022 10:45am

Leo Pharma's new CEO comes from failed meme stock Orphazyme

Jan 31, 2022 12:09pm
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
  • ©2022 Questex LLC All rights reserved.
  • Terms of use
  • Privacy Policy